Scolaris Content Display Scolaris Content Display

Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

This is not the most recent version

References

Additional references

Appleton 2006

Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson Toby J, et al. Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001387.pub2]

ATS/ERS 2004

Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(6):932‐46. [(Print)]

Barr 2005

Barr RG, Bourbeau J, Camargo Carlos A. Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002876.pub2]

Beeh 2010

Beeh KM, Beier J. The Short, the Long, and the "Ultra‐long": Why Duration of Bronchodilator Action Matters in Chronic Obstructive Pulmonary Disease. Advances in Therapy 2010;27(3):150‐9.

Berger 2008

Berger WE, Nadel JA. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. Respiratory Medicine2008; Vol. 102, issue 2:173‐88. [(Print)]

Decramer 2013

Decramer ML, Hanania NA, Lotvall, JO, Yawn BP. The safety of long‐acting β2‐agonistsin the treatment of stable chronic obstructive pulmonary disease. International Journal of COPD 2013;8:53‐64.

Dias 2010

Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta‐analysis. Statistics in Medicine 2010;29(7‐8):932‐44.

Dias 2011

Dias S, Welton NJ, Sutton AJ, Caldwell DM, Guobing L, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. 2011; last updated April 2012. http://www.nicedsu.org.uk (accessed 3/10/13).

Dias 2012

Dias S, Sutton AJ, Ades AE, Welton NJ. A Generalized Linear Modeling Framework for Pairwise and Network Meta‐analysis of Randomized Controlled Trials. Medical Decision Making 2012 Oct 26 [Epub ahead of print].

Dong 2013

Dong Y, Lin H, Shau W, Wu Y, Chang C, Lai M. Comparative safety of inhaled medications inpatients with chronic obstructive pulmonary disease:systematic review and mixed treatment comparison meta‐analysis of randomised controlled trials. Thorax 2013;68:48‐56.

Effing 2007

Effing T, Monninkhof Evelyn EM, van der Valk Paul PDLPM, Zielhuis Gerhard GA, Walters EH, van der Palen Job J, et al. Self‐management education for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD002990.pub2]

GOLD

From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. http://www.goldcopd.com (accessed 3/10/13).

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org2011.

Higgins 2012

Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studies. Research Synthesis Methods2012; Vol. 3, issue 2:98‐110. [1759‐2887]

Hutchinson 2010

Hutchinson A, Brand C, Irving L, Roberts C, Thompson P, Campbell D. Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure. Internal Medicine Journal 2010;40(5):364‐71.

Lacasse 2006

Lacasse Y, Goldstein R, Lasserson Toby J, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD003793.pub2]

Loke 2011

Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta‐analysis of randomised controlled trials and observational studies. Thorax. 2011/05/24 2011; Vol. 66, issue 8:699‐708. [(Electronic)]

Lu 2006

Lu G, Ades A. Assessing evidence consistency in mixed treatment comparisons. Journal of the American Statistical Association 2006;101:447‐59.

Moen 2010

Moen MD. Indacaterol: in chronic obstructive pulmonary disease. Drugs 2010;70(17):2269‐80. [(Print)]

NICE 2011

National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease, Costing report, Implementing NICE guidance. http://guidance.nice.org.uk/CG101/CostingReport/pdf/English (accessed 3/10/13).

Puhan 2011

Puhan MA, Gimeno‐Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD005305.pub3]

Rodrigo 2008

Rodrigo GJ, Nannini LJ, Rodríguez‐Roisin R. Safety of long‐acting β‐agonists in stable COPD: A systematic review. Chest 2008;133(5):1079‐87.

Rodrigo 2009

Rodrigo GJ, Castro‐Rodriguez JA, Plaza V. Safety and efficacy of combined long‐acting beta‐agonists and inhaled corticosteroids vs long‐acting beta‐agonists monotherapy for stable COPD: a systematic review. Chest 2009;136(4):1029‐38. [(Electronic)]

Sestini 2009

Sestini P, Renzoni E, Robinson S, Poole P, Ram FSF. Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD001495]

Singh 2010

Singh S, Loke YK. An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 2010;5:189‐95.

Spiegelhalter 2002

Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society. Series B (Statistical Methodology) 2002;64(4):583‐639.

Tashkin 2008

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4‐year trial of tiotropium in chronic obstructive pulmonary disease. New England Journal of Medicine 2008;359(15):1543‐54.

van der Meer 2001

van der Meer Regina M, Wagena E, Ostelo Raymond WJG, Jacobs Annelies JE, van Schayck O. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002999]

White 2012

White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regression. Research Synthesis Methods 2012;3(2):111‐25. [1759‐2887]

WHO

World Health Organization. Chronic Respiratory Diseases. http://www.who.int/respiratory/en/ (accessed 3/10/13).